S100A12 also exists in a dimer or hexamer form, and Ca2+-bound forms of S100A12 are reported to bind directly to soluble tumor necrosis factor (TNF) and affect the efficacy of anti-TNF therapy in patients with juvenile idiopathic arthritis and Crohn’s disease [29]. Here, S100A12 is linked to juvenile idiopathic arthritis.